Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pathophysiology and management of alzheimer’s disease: an overview
Ajit Kumar Thakur, Parul Kamboj, Kritika Goswami, et al.
Journal of Analytical & Pharmaceutical Research (2018) Vol. 7, Iss. 2
Open Access | Times Cited: 118

Showing 26-50 of 118 citing articles:

The Potential Neuroprotective Effect of Cyperus esculentus L. Extract in Scopolamine-Induced Cognitive Impairment in Rats: Extensive Biological and Metabolomics Approaches
Marwa M. Saeed, Álvaro Fernández‐Ochoa, Fatema R. Saber, et al.
Molecules (2022) Vol. 27, Iss. 20, pp. 7118-7118
Open Access | Times Cited: 9
Hyperconnectivity matters in early-onset Alzheimer's disease: a resting-state EEG connectivity study
Ezgi Fide, Duygu Hünerli-Gündüz, İ̇brahim Öztura, et al.
Neurophysiologie Clinique (2022) Vol. 52, Iss. 6, pp. 459-471
Closed Access | Times Cited: 9
Advances in the pathogenesis of Alzheimer’s disease: A re-evaluation of the Amyloid cascade hypothesis
Leo Clinton Chukwu, John A. Ekenjoku, Sylvester C. Ohadoma, et al.
World Journal of Advanced Research and Reviews (2023) Vol. 17, Iss. 2, pp. 882-904
Open Access | Times Cited: 5
Nanoparticles Based Intranasal Delivery of Drug to Treat Alzheimer’s Disease: A Recent Update
Manisha Pandey, Hira Choudhury, Rohit Kumar Verma, et al.
CNS & Neurological Disorders - Drug Targets (2020) Vol. 19, Iss. 9, pp. 648-662
Closed Access | Times Cited: 13
An overview on therapeutic and medicinal potential of poly-hydroxy flavone viz. Heptamethoxyflavone, Kaempferitrin, Vitexin and Amentoflavone for management of Alzheimer’s and Parkinson’s diseases: a critical analysis on mechanistic insight
Mansi Varshney, Bhavna Kumar, Vijay Singh Rana, et al.
Critical Reviews in Food Science and Nutrition (2021) Vol. 63, Iss. 16, pp. 2749-2772
Closed Access | Times Cited: 12
An Insight into the Role of Artificial Intelligence in the Early Diagnosis of Alzheimer’s Disease
Rohit Kumar Verma, Pooja A. Chawla, Manisha Pandey, et al.
CNS & Neurological Disorders - Drug Targets (2021) Vol. 21, Iss. 10, pp. 901-912
Closed Access | Times Cited: 11
Structural fingerprinting of pleiotropic flavonoids for multifaceted Alzheimer's disease
Amisha Punmiya, Arati Prabhu
Neurochemistry International (2023) Vol. 163, pp. 105486-105486
Closed Access | Times Cited: 4
Role of angiotensin receptor blockers in the context of Alzheimer's disease
Binal Kuber, Mitisha Fadnavis, Bappaditya Chatterjee
Fundamental and Clinical Pharmacology (2023) Vol. 37, Iss. 3, pp. 429-445
Closed Access | Times Cited: 4
Roles of nano medicine in diagnosis of Alzheimer's disease
Mona Amit Kaushal, Nikita Patel, Gauravi Xavier, et al.
Elsevier eBooks (2024), pp. 115-138
Closed Access | Times Cited: 1
The promising role of bioactive congeners present in Cassytha filiformis in Alzheimer's disease: An explicative review
Rakhi Khabiya, Dipanjan Karati, S. N. Dwivedi, et al.
Brain Disorders (2024) Vol. 13, pp. 100125-100125
Open Access | Times Cited: 1
The evolution of Alzheimer’s disease therapies: A comprehensive review
Pritama Paul, Abhishek Bhattacharjee, Susanta Kumar Bordoloi, et al.
Annals of Medical Science and Research (2024) Vol. 3, Iss. 1, pp. 11-19
Closed Access | Times Cited: 1
Terapéutica con anticuerpos monoclonales en la enfermedad de Alzheimer
Johanna Abigail Maliza-Moposita, Luis Fabián Salazar-Garcés
MQRInvestigar (2024) Vol. 8, Iss. 3, pp. 2739-2760
Open Access | Times Cited: 1
Basic approach on the protective effects of hesperidin and naringin in Alzheimer’s disease
Müjgan Kuşi, Eda Becer, Seda Vatansever
Nutritional Neuroscience (2024), pp. 1-13
Closed Access | Times Cited: 1
Unlocking the Potential: Woodfordia fruticosa Kurz in Alzheimer's Disease Management - A Concise Review
Sanjukta Sen, Shreyasi Meur, Gouranga Nandi, et al.
Brain Disorders (2024), pp. 100171-100171
Open Access | Times Cited: 1
Exploring DPP IV inhibitors for Alzheimer’s disease: Bridging diabetes and neurodegeneration
Swagata Pattanaik, Shakti Ketan Prusty, Pratap Kumar Sahu
Brain Research (2024) Vol. 1848, pp. 149342-149342
Closed Access | Times Cited: 1
Diagnosis and management of neurodegenerative diseases
Pooja Kagawad, Parixit Bhandurge, Shankar Gharge
Elsevier eBooks (2024), pp. 101-114
Closed Access | Times Cited: 1
Role of multi-targeted bioactive natural molecules and their derivatives in the treatment of Alzheimer’s disease: an insight into structure-activity relationship
Debojyoti Halder, Subham Das, R. S. Jeyaprakash, et al.
Journal of Biomolecular Structure and Dynamics (2022) Vol. 41, Iss. 20, pp. 11286-11323
Closed Access | Times Cited: 7
Acetylcholinesterase inhibitory activity of extract and fractions from the root of Rauvolfia serpentina(L.) Bth.ex Kurz
Suciati Suciati, Debora Poerwantoro, Aty Widyawaruyanti, et al.
Journal of Basic and Clinical Physiology and Pharmacology (2021) Vol. 32, Iss. 4, pp. 313-317
Open Access | Times Cited: 8
RETRACTED: Development of carbon dots to manage Alzheimer's disease and Parkinson's disease
Yung‐Chih Kuo, Sourav De
Journal of the Taiwan Institute of Chemical Engineers (2023) Vol. 146, pp. 104799-104799
Open Access | Times Cited: 2
Job Related Burnout among Emergency Physicians and Nurses in Dammam City, Saudi Arabia
Abdulaziz F. Alshahrani, Abdullah M. Alhotheyfa, Salman Z. Alkhiraisy, et al.
World Family Medicine Journal/Middle East Journal of Family Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 4
Exploring the Treatment Types and Challenges in Patients with Chronic Obstructive Pulmonary Disease: A Qualitative Study
Mian Ali Kamran Baba, Shaheer Ellahi Khan, Fatima Hasnain, et al.
World Family Medicine Journal/Middle East Journal of Family Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 4
Public Awareness, and Perception towards Chronic Kidney Disease and its Risk Factors in Southern Region, Saudi Arabia
Mona Mohammed Alshahrani, Haifa’ Hisham A. Alwabel, Hassan Dhafer Hassan Alabisi, et al.
World Family Medicine Journal/Middle East Journal of Family Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 4
The potential role of Piper guineense (black pepper) in managing geriatric brain aging: a review
Oluwaseun Hannah Ademuyiwa, Beatrice Mofoluwaso Fasogbon, Oluwafemi Ayodeji Adebo
Critical Reviews in Food Science and Nutrition (2021) Vol. 63, Iss. 16, pp. 2840-2850
Open Access | Times Cited: 5
Chimeric Conjugates for Alzheimer’s Disease
Illham Dhala, Tabassum Khan, Arati Prabhu
Exon Publications eBooks (2020), pp. 165-180
Open Access | Times Cited: 4
Why patients go to private health care facilities? Perspectives from Qassim, Saudi Arabia
Amel A. Sulaiman, Unaib Rabbani, Sultan S. AlShaya, et al.
World Family Medicine Journal/Middle East Journal of Family Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 3

Scroll to top